Company intelligence / Profile preview

CheckOrphan

Basel, Basel-Stadt, Switzerland

Ownership: Private
Development stage: Other

Overview

CheckOrphan is a non-profit organization and global information hub dedicated to rare diseases and orphan drugs. Based in Basel, Switzerland, the platform centralizes news, clinical trials, research, and resources to support patients, healthcare professionals, and the pharmaceutical industry. By providing a comprehensive database of rare disease information, CheckOrphan aims to accelerate the development of treatments and improve the lives of those affected by rare conditions. The organization facilitates collaboration across the rare disease community through its digital platform and networking initiatives.

Therapeutic areas: Rare Diseases
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

EURORDISNORDGlobal Genes

Beyond the preview

Go deeper on CheckOrphan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CheckOrphan.

Explore the full profile